Cargando...
NK-92 cellular therapy for pediatric relapsed/refractory Ewing sarcoma
Relapsed/refractory Ewing sarcoma prognosis is dreadful, especially for recurrences within the first 2 years after initial diagnosis. It is obvious that there is an urgent need for novel treatment strategies for this dismal situation. NK-92 is an activated NK cell line with high cytotoxicity against...
Guardado en:
| Publicado en: | Int Cancer Conf J |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Singapore
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7297928/ https://ncbi.nlm.nih.gov/pubmed/32582518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00406-6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|